Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date.

Autor: Hanley B; Department of Cellular & Molecular Pathology, Northwest London Pathology, Imperial College Healthcare NHS Trust & Department of Immunology & Inflammation, Imperial College London, London, UK., Roufosse CA; Department of Cellular & Molecular Pathology, Northwest London Pathology, Imperial College Healthcare NHS Trust & Department of Immunology & Inflammation, Imperial College London, London, UK., Osborn M; Department of Cellular & Molecular Pathology, Northwest London Pathology, Imperial College Healthcare NHS Trust & Department of Immunology & Inflammation, Imperial College London, London, UK., Naresh KN; Department of Cellular & Molecular Pathology, Northwest London Pathology, Imperial College Healthcare NHS Trust & Department of Immunology & Inflammation, Imperial College London, London, UK.
Jazyk: angličtina
Zdroj: British journal of haematology [Br J Haematol] 2020 Jun; Vol. 189 (6), pp. 1062-1063. Date of Electronic Publication: 2020 May 19.
DOI: 10.1111/bjh.16780
Databáze: MEDLINE
Externí odkaz: